At a time when there is mounting pressure on the NHS, with 6.73 million people waiting for treatment in England, group risk can bridge the treatment gap and offer a much-needed route to health and financial support, writes Canada Life's Ian Ranger.
With 6.8 million people now on the waiting list for treatment in England, the NHS has a huge mountain to climb. As these pressures continue to mount, and the number of people struggling to access treatment continues to grow, the insurance industry and employers are looking at how the treatment gap can be bridged. As a result, group risk products have come to the fore. Understanding the value First and foremost, employer and employee understanding of the value group protection products can provide has never been better as the pandemic alerted people to the importance of health and w...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
